Osteoporosis historical perspective

Jump to navigation Jump to search

Osteoporosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Osteoporosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Life Style Modification
Pharmacotherapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Osteoporosis historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Osteoporosis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Osteoporosis historical perspective

CDC on Osteoporosis historical perspective

Osteoporosis historical perspective in the news

Blogs on Osteoporosis historical perspective

Directions to Hospitals Treating Osteoporosis

Risk calculators and risk factors for Osteoporosis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Charmaine Patel, M.D. [3]

Overview

Historical Perspective

The bone disease, osteoporosis, was first seen in Egyptian mummies from over 4000 years ago, which showed the telltale sign of osteoporosis called "Dowager's Hump". John Hunter, a surgeon from the 1800's, was the first person to recognize that old bone which is resorbed by the body and destroyed, is replaced by new bone being laid down. In the 1830's, the French pathologist, Jean Georges Chretien Frederic Martin Lobstein noticed that some persons had bones with larger than normal holes in them. He coined the term "osteoporosis" to describe the porous bone. Many developments have been made in the treatment and prevention of osteoporosis over the years, however osteoporosis remains a significant challenge within the field of medicine.

  • The link between age-related reductions in bone density, and fracture risk goes back to Astley Cooper, and the term "osteoporosis" and recognition of its pathological appearance in the 1830's is generally attributed to the French pathologist Lobstein.[1]
  • The American endocrinologist Fuller Albright of Massachusetts General Hospital, linked osteoporosis with the postmenopausal state.[2]
  • In the 1940's, Fuller Albright started treating menopausal women with estrogen to prevent further bone loss.
  • In the 1960's, researchers developed more sensitive methods to detect early bone loss, such as densitometers.
  • Bisphosponates which inhibit bone resorption, and revolutionized the treatment of osteoporosis, and were discovered in the 1960s by Herbert Fleisch.[3]
  • In 1984, the National Institute of Health (NIH) publicized this disease, and brought attention to osteoporosis as a significant threat to health, with the emphasis that bone loss could be reduced by estrogen therapy, calcium supplementation, good nutrition, and exercise
  • In the 1980's and 1990's researchers discovered the specific cytokines which influence the activity of osteoclasts, the components that cause bone breakdown.
  • SERM's (Selective Estrogen Receptor Modulators) such as raloxifene entered the market around 1998. They have been found to also block breast tumors and to stimulate the growth of uterine cells.

References

  1. Lobstein JGCFM. Lehrbuch der pathologischen Anatomie. Stuttgart: Bd II, 1835.
  2. Albright F, Bloomberg E, Smith PH (1940). "Postmenopausal osteoporosis". Trans. Assoc. Am. Physicians. 55: 298–305.
  3. Patlak M (2001). "Bone builders: the discoveries behind preventing and treating osteoporosis". FASEB J. 15 (10): 1677E–E. PMID 11481214.

Template:WH Template:WS